Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach

References

• Spiller RC. Irritable bowel syndrome. Br Med Bull. 2004;72:15–29.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2013;14(9):1151–1160.
   PubMed Web of Science ®Google Scholar
• Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71–80.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.
   PubMed Web of Science ®Google Scholar
• Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016;2:16014.
   PubMed Web of Science ®Google Scholar
• Abraham BP, Sellin JH. Disability in inflammatory bowel disease. Gastroenterol Clin North Am. 2012;41(2):429–441.
   PubMed Web of Science ®Google Scholar
• Lo B, Prosberg MV, Gluud LL, et al. Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index. Aliment Pharmacol Ther. 2018;47(1):6–15.
   PubMed Web of Science ®Google Scholar
• Card TR, Siffledeen J, Fleming KM. Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database. United Eur Gastroenterol J. 2014;2(6):505–512.
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a lowgrade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34(2):235–245.
   PubMed Web of Science ®Google Scholar
• Cantoro L, Di Sabatino A, Papi C, et al. The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian Multicentre Study. J Crohns Colitis. 2017;11(8):975–980.
   PubMed Web of Science ®Google Scholar
• Nguyen VQ, Jiang D, Hoffman SN, et al. Impact of diagnostic delay and associated factors on clinical outcomes in a U.S. Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis. 2017;23:1825–1831.
   PubMed Web of Science ®Google Scholar
• Ministro P, Martins D. Fecal biomarkers in inflammatory bowel disease: how, when and why? Expert Rev Gastroenterol Hepatol. 2017;11(4):317–328.
   PubMed Web of Science ®Google Scholar
• Fagerhol M, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Eur Physiopathol Respir. 1980;16(Suppl.):273–282.
   PubMedGoogle Scholar
• Hsu K, Champaiboon C, Guenther BD, et al. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem. 2009;8(4):290–305.
   PubMedGoogle Scholar
• Von Roon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007;102(4):803–813.
   PubMed Web of Science ®Google Scholar
• Van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369.
   PubMed Web of Science ®Google Scholar
• Lee KM. Fecal biomarkers in inflammatory bowel disease. Intest Res. 2013;11(2):73–78.
   Google Scholar
• An YK, Prince D, Gardiner F, et al. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis. Med J Aust. 2019;211(10):461–467.
   PubMed Web of Science ®Google Scholar
• Clamp SE, Myren J, Bouchier IA, et al. Diagnosis of inflammatory bowel disease: an international multicentre scoring system. Br Med J (Clin Res Ed). 1982;284(6309):91–95.
   PubMed Web of Science ®Google Scholar
• Chmiel C, Vavricka SR, Hasler S, et al. Feasibility of an 8-item questionnaire for early diagnosis of inflammatory bowel disease in primary care. J Eval Clin Pract. 2019;25(1):155–162.
   PubMed Web of Science ®Google Scholar
• Danese S, Fiorino G, Mary JY, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn's disease: an IOIBD initiative. J Crohns Colitis. 2015;9(8):601–606.
   PubMed Web of Science ®Google Scholar
• Reenaers C, Bossuyt P, Hindryckx P, et al. Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United Eur Gastroenterol J. 2018;6(8):1117–1125.
   PubMed Web of Science ®Google Scholar
• Kohn MA, Carpenter CR, Newman TB. Understanding the direction of bias in studies of diagnostic test accuracy. Acad Emerg Med. 2013;20(11):1194–1206.
   PubMed Web of Science ®Google Scholar
• de Groot JA, Dendukuri N, Janssen KJ, et al. Adjusting for differential-verification bias in diagnostic-accuracy studies: a Bayesian approach. Epidemiology. 2011;22(2):234–241.
   PubMed Web of Science ®Google Scholar
• Joseph L, Gyorkos TW, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol. 1995;141(3):263–272.
   PubMed Web of Science ®Google Scholar
• Sturtz S, Ligges U, Gelman A. R2WinBUGS: a package for running WinBUGS from R. J Stat Soft. 2005;12(3):1–16.
   Web of Science ®Google Scholar
• Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Statist Sci. 1992;7(4):457–511.
   Google Scholar
• Plummer M, Best N, Cowles K, et al. CODA: convergence diagnosis and output analysis for MCMC. R News. 2006;6:7–11.
   Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35.
   PubMed Web of Science ®Google Scholar
• Kok L, Elias SG, Witteman BJ, et al. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study. Clin Chem. 2012;58(6):989–998.
   PubMed Web of Science ®Google Scholar
• Turvill J, O'Connell S, Brooks A, et al. Evaluation of a faecal calprotectin care pathway for use in primary care. Prim Health Care Res Dev. 2016;17(5):428–436.
   PubMed Web of Science ®Google Scholar
• Högberg C, Karling P, Rutegård J, et al. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: the usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study. Scand J Gastroenterol. 2017;52(1):69–75.
   PubMed Web of Science ®Google Scholar
• Conroy S, Hale MF, Cross SS, et al. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care. J Clin Pathol. 2018;71(4):316–322.
   PubMed Web of Science ®Google Scholar
• Walker GJ, Moore L, Heerasing N, et al. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study. Aliment Pharmacol Ther. 2018;47(8):1103–1116.
   PubMed Web of Science ®Google Scholar
• Turvill J, Turnock D, Holmes H, et al. Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care Pathway. Frontline Gastroenterol. 2018;9(4):285–294.
   PubMed Web of Science ®Google Scholar
• Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, et al. Diagnostic accuracy of fecal calprotectin for pediatric inflammatory bowel disease in primary care: a prospective cohort study. Ann Fam Med. 2016;14(5):437–445.
   PubMed Web of Science ®Google Scholar
• Pavlidis P, Chedgy FJ, Tibble JA. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care. Scand J Gastroenterol. 2013;48(9):1048–1054.
   PubMed Web of Science ®Google Scholar
• Ramraj R, Garcia A, Mosen D, et al. Utility of fecal calprotectin in evaluation of chronic gastrointestinal symptoms in primary care. Clin Pediatr (Phila). 2018;57(9):1058–1063.
   PubMed Web of Science ®Google Scholar
• Chmiel C, Senn O, Hasler S, et al. Can the CalproQuest predict a positive calprotectin test? A prospective diagnostic study. PLoS One. 2019;14(11):e0224961.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wong CH, Chavannes M, et al. Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease. BMJ Open. 2019;9(4):e027043.
   PubMed Web of Science ®Google Scholar
• Yang Z, Clark N, Park KT. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children. Clin Gastroenterol Hepatol. 2014;12(2):253–262.
   PubMed Web of Science ®Google Scholar